statistiche ricercatore

Continente	#
NA - Nord America	1.289
AS - Asia	850
EU - Europa	801
SA - Sud America	116
Continente sconosciuto - Info sul continente non disponibili	35
AF - Africa	20
OC - Oceania	2
Totale	3.113

Nazione	#
US - Stati Uniti d'America	1.230
IT - Italia	343
SG - Singapore	324
CN - Cina	192
HK - Hong Kong	109
RU - Federazione Russa	102
BR - Brasile	82
DE - Germania	77
VN - Vietnam	76
GB - Regno Unito	57
IE - Irlanda	42
CA - Canada	37
SE - Svezia	36
FR - Francia	29
IN - India	28
FI - Finlandia	25
KR - Corea	23
CH - Svizzera	19
ES - Italia	18
ID - Indonesia	17
BD - Bangladesh	16
IQ - Iraq	13
PL - Polonia	13
AR - Argentina	12
JP - Giappone	11
NL - Olanda	11
TR - Turchia	10
MX - Messico	9
ZA - Sudafrica	9
PK - Pakistan	8
SA - Arabia Saudita	8
AT - Austria	7
CO - Colombia	7
EC - Ecuador	7
LT - Lituania	5
JM - Giamaica	4
UA - Ucraina	4
EG - Egitto	3
JO - Giordania	3
MA - Marocco	3
AL - Albania	2
BG - Bulgaria	2
CR - Costa Rica	2
GA - Gabon	2
GT - Guatemala	2
PH - Filippine	2
RS - Serbia	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AU - Australia	1
BA - Bosnia-Erzegovina	1
CL - Cile	1
CZ - Repubblica Ceca	1
GN - Guinea	1
HN - Honduras	1
IL - Israele	1
KG - Kirghizistan	1
KH - Cambogia	1
LI - Liechtenstein	1
LK - Sri Lanka	1
MK - Macedonia	1
MU - Mauritius	1
NO - Norvegia	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PT - Portogallo	1
PY - Paraguay	1
QA - Qatar	1
RO - Romania	1
SR - Suriname	1
SV - El Salvador	1
TH - Thailandia	1
TJ - Tagikistan	1
UZ - Uzbekistan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	3.079

Nome	#
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	387
Autoimmune liver diseases	321
Clinical treatment of cholangiocarcinoma: an updated comprehensive review	313
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid	291
Artificial intelligence for precision medicine in autoimmune liver disease	283
Early Gastric Cancer: Update on Prevention, Diagnosis and Treatment	269
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis	240
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease	227
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review	220
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?	213
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis	208
Prognostic Scoring Systems in Primary Biliary Cholangitis: An Update	141
Totale	3.113

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	170	0	0	5	15	29	27	23	8	17	16	10	20
2023/2024	334	12	19	22	34	37	49	40	7	16	29	9	60
2024/2025	566	41	33	48	33	43	38	32	16	50	96	67	69
2025/2026	1.504	152	72	89	184	187	81	251	76	124	151	51	86
2026/2027	539	118	63	173	185	0	0	0	0	0	0	0	0
Totale													3.113

Bicocca Open Archive